THE DEAL, AT A GLANCE
From the announcementSift Biosciences
01What it doesSift Biosciences is a Enterprise Technology company focused on Advance T-cell Immunotherapy Platform.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedSift Biosciences raised $3.7M Pre-Seed, announced 2026-05-31From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersSift Biosciences’ $3.7M Pre-Seed round is a small-position FinTech allocation in a very active funding category, with round size sitting at the 13th percentile of…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Sift Biosciences · Financing Record
Explore source-linked visual explanations for Sift Biosciences. Unsupported claims are withheld while source review continues.
Record 4903 · Recorded date: 2026-05-31
Explore company records →